Table 6

Multiple-variable model comparing cases only by transplant type, current immunosuppressant status, body mass index, sex, race/ethnicity, age at transplantation, and age at interview

Diabetes
Hypertension
Arterial disease
MI
Stroke
OR95% CIPOR95% CIPOR95% CIPOR95% CIPOR95% CIP
Transplant type                
    Autologous Ref   Ref   Ref   Ref   Ref   
    Allogeneic 1.60 0.83-3.11 .16 2.31 1.45-3.67 < .001 1.79 0.26-12.56 .56 1.42 0.20-10.03 .72 0.84 0.13-5.25 .85 
Sex                
    Male Ref   Ref   Ref   Ref   Ref   
    Female 0.72 0.44-1.18 .20 0.92 0.66-1.28 .61 0.10 0.01-0.81 .03 1.04 0.27-4.05 .95 1.19 0.29-4.90 .81 
Race/ethnicity                
    White Ref   Ref   Ref   Ref   Ref   
    Hispanic 2.52 1.38-4.57 .003 0.57 0.33-0.96 .04 NE   NE   NE   
    Other 2.86 1.26-6.50 .01 0.65 0.32-1.32 .23 NE   NE   NE   
Age at transplantation, y 0.92 0.88-0.96 < .001 1.00 0.96-1.03 .81 0.92 0.83-1.03 .15 0.96 0.84-1.10 .55 0.95 0.84-1.08 .46 
Age at interview, y 1.14 1.08-1.20 < .001 1.06 1.02-1.10 .001 1.26 1.10-1.44 < .001 1.16 0.98-1.36 .08 1.04 0.91-1.19 .58 
BMI 1.14 1.08-1.18 < .001 1.05 1.01-1.08 .004 0.97 0.84-1.12 .70 0.96 0.82-1.11 .55 0.94 0.80-1.11 .49 
Conditioning                
    Chemotherapy Ref   Ref   Ref   Ref   Ref   
    TBI and chemotherapy 3.42 1.55-7.52 .002 0.71 0.48-1.06 .10 1.56 0.30-8.09 .59 1.18 0.22-6.28 .85 2.40 0.27-21.07  
Chronic GVHD                
    No Ref   Ref   Ref   Ref   Ref   
    Yes 0.71 0.38-1.34 .29 1.09 0.70-1.71 .70 2.44 0.46-12.94 .30 0.99 0.13-7.3 .99 1.16 0.18-7.45 .87 
Diabetes
Hypertension
Arterial disease
MI
Stroke
OR95% CIPOR95% CIPOR95% CIPOR95% CIPOR95% CIP
Transplant type                
    Autologous Ref   Ref   Ref   Ref   Ref   
    Allogeneic 1.60 0.83-3.11 .16 2.31 1.45-3.67 < .001 1.79 0.26-12.56 .56 1.42 0.20-10.03 .72 0.84 0.13-5.25 .85 
Sex                
    Male Ref   Ref   Ref   Ref   Ref   
    Female 0.72 0.44-1.18 .20 0.92 0.66-1.28 .61 0.10 0.01-0.81 .03 1.04 0.27-4.05 .95 1.19 0.29-4.90 .81 
Race/ethnicity                
    White Ref   Ref   Ref   Ref   Ref   
    Hispanic 2.52 1.38-4.57 .003 0.57 0.33-0.96 .04 NE   NE   NE   
    Other 2.86 1.26-6.50 .01 0.65 0.32-1.32 .23 NE   NE   NE   
Age at transplantation, y 0.92 0.88-0.96 < .001 1.00 0.96-1.03 .81 0.92 0.83-1.03 .15 0.96 0.84-1.10 .55 0.95 0.84-1.08 .46 
Age at interview, y 1.14 1.08-1.20 < .001 1.06 1.02-1.10 .001 1.26 1.10-1.44 < .001 1.16 0.98-1.36 .08 1.04 0.91-1.19 .58 
BMI 1.14 1.08-1.18 < .001 1.05 1.01-1.08 .004 0.97 0.84-1.12 .70 0.96 0.82-1.11 .55 0.94 0.80-1.11 .49 
Conditioning                
    Chemotherapy Ref   Ref   Ref   Ref   Ref   
    TBI and chemotherapy 3.42 1.55-7.52 .002 0.71 0.48-1.06 .10 1.56 0.30-8.09 .59 1.18 0.22-6.28 .85 2.40 0.27-21.07  
Chronic GVHD                
    No Ref   Ref   Ref   Ref   Ref   
    Yes 0.71 0.38-1.34 .29 1.09 0.70-1.71 .70 2.44 0.46-12.94 .30 0.99 0.13-7.3 .99 1.16 0.18-7.45 .87 

NE indicates not estimable because no outcome in one or more categories; and Ref, reference category.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal